Lisi, Lucia

Lisi, Lucia  

Mostra records
Risultati 1 - 20 di 54 (tempo di esecuzione: 0.264 secondi).
Data di pubblicazione Titolo Autore(i) File
1-gen-2022 Clinical experience with CTLA-4 blockade for cancer immunotherapy: From the monospecific monoclonal antibody ipilimumab to probodies and bispecific molecules targeting the tumor microenvironment Lisi, L.; Lacal, P. M.; Martire, M.; Navarra, P.; Graziani, G.
1-gen-2022 The effects of CHF6467, a new mutated form of NGF, on cell models of human glioblastoma. A comparison with wild-type NGF Lisi, Lucia; Ciotti, Gabriella Maria Pia; Chiavari, Marta; Martire, Maria; Navarra, Pierluigi
1-gen-2020 Approaching coronavirus disease 2019: Mechanisms of action of repurposed drugs with potential activity against SARS-CoV-2 Lisi, L.; Lacal, P. M.; Barbaccia, M. L.; Graziani, G.
1-gen-2020 Development of an uplc-ms/ms method for quantitative analysis of clotrimazole in human plasma samples Lisi, L.; Ciotti, G. M. P.; Navarra, P.
1-gen-2020 DNA inhibitors for the treatment of brain tumors Lisi, Lucia; Chiavari, Marta; Ciotti, Gabriella Maria Pia; Lacal, Pedro M; Navarra, Pierluigi; Graziani, Grazia
1-gen-2020 Pdia3 expression in glioblastoma modulates macrophage/microglia pro-tumor activation Chiavari, M.; Ciotti, G. M. P.; Canonico, F.; Altieri, F.; Lacal, P. M.; Graziani, G.; Navarra, P.; Lisi, L.
1-gen-2020 Pharmacokinetics of high-dose tigecycline in critically ill patients with severe infections De Pascale, G.; Lisi, L.; Ciotti, G. M. P.; Vallecoccia, M. S.; Cutuli, S. L.; Cascarano, L.; Gelormini, C.; Bello, G.; Montini, L.; Carelli, S.; Di Gravio, V.; Tumbarello, M.; Sanguinetti, M.; Navarra, P.; Antonelli, M.
1-gen-2020 Pharmacokinetics of high-dose tigecycline in critically ill patients with severe infections 1 2, Gennaro De Pascale; Lisi, Lucia; 3 4, Gabriella Maria Pia Ciotti; 5 6, Maria Sole Vallecoccia; 5 6, Salvatore Lucio Cutuli; 5 6, Laura Cascarano; 5 6, Camilla Gelormini; 5 6, Giuseppe Bello; 5 6, Luca Montini; 5 6, Simone Carelli; 5 6, Valentina Di Gravio; 7 8, Mario Tumbarello; Sanguinetti, Maurizio; 3 4, Pierluigi Navarra; Antonelli, Massimo
1-gen-2020 Tigecycline pharmacokinetics in critically ill patients on renal replacement therapy: possible warnings and potential perspectives for the research agenda Cutuli, S. L.; De Pascale, G.; Lisi, L.; Carelli, S.; Navarra, P.; Antonelli, M.
1-gen-2020 Vascular endothelial growth factor receptor 1 in glioblastoma-associated microglia/macrophages Lisi, L.; Ciotti, G. M. P.; Chiavari, M.; Ruffini, F.; Lacal, P. M.; Graziani, G.; Navarra, P.
1-gen-2019 Neuronal Conditional Knockout of Collapsin Response Mediator Protein 2 Ameliorates Disease Severity in a Mouse Model of Multiple Sclerosis Lisi, Lucia; Feinstein, Douglas L
1-gen-2019 Phospho-mTOR expression in human glioblastoma microglia-macrophage cells Lisi, L.; Ciotti, G. M. P.; Chiavari, M.; Pizzoferrato, M.; Mangiola, A.; Kalinin, S.; Feinstein, D. L.; Navarra, P.
1-gen-2019 Pro-inflammatory activation of a new immortalized human microglia cell line Chiavari, M.; Ciotti, G. M. P.; Navarra, P.; Lisi, L.
1-gen-2018 Transcriptome analysis of alcohol-treated microglia reveals downregulation of beta amyloid phagocytosis Kalinin, Sergey; González-Prieto, Marta; Scheiblich, Hannah; Lisi, Lucia; Kusumo, Handojo; Heneka, Michael T; Madrigal, Jose L M; Pandey, Subhash C; Feinstein, Douglas L
1-gen-2017 Blockade of CCR5 receptor prevents M2 microglia phenotype in a microglia-glioma paradigm Laudati, Emilia; Curro', Diego; Navarra, Pierluigi; Lisi, Lucia
1-gen-2017 Exploiting microglial functions for the treatment of glioblastoma Dello Russo, Cinzia; Lisi, Lucia; Tentori, Lucio; Navarra, Pierluigi; Graziani, Grazia; Combs, Colin K.
1-gen-2017 Expression of iNOS, CD163 and ARG-1 taken as M1 and M2 markers of microglial polarization in human glioblastoma and the surrounding normal parenchyma Lisi, Lucia; Ciotti, Gabriella Maria Pia; Braun, D.; Kalinin, S.; Curro', Diego; Dello Russo, Cinzia; Coli, Antonella; Mangiola, Annunziato; Anile, Carmelo; Feinstein, D. L.; Navarra, Pierluigi
1-gen-2017 Interactions between Integrase Inhibitors and human Arginase 1 Lisi, Lucia; Pizzoferrato, Michela; Miscioscia, Fabiola Teresa; Topai, Alessandra; Navarra, Pierluigi
1-gen-2017 Switch to maraviroc with darunavir/r, both QD, in patients with suppressed HIV-1 was well tolerated but virologically inferior to standard antiretroviral therapy: 48-Week results of a randomized trial Rossetti, Barbara; Gagliardini, Roberta; Meini, Genny; Sterrantino, Gaetana; Colangeli, Vincenzo; Re, Maria Carla; Latini, Alessandra; Colafigli, Manuela; Vignale, Francesca; Rusconi, Stefano; Micheli, Valeria; Biagio, Antonio Di; Orofino, Giancarlo; Ghisetti, Valeria; Fantauzzi, Alessandra; Vullo, Vincenzo; Grima, Pierfrancesco; Francisci, Daniela; Mastroianni, Claudio; Antinori, Andrea; Trezzi, Michele; Lisi, Lucia; Navarra, Pierluigi; Canovari, Benedetta; D’Arminio Monforte, Antonella; Lamonica, Silvia; D’Avino, Alessandro; Zazzi, Maurizio; Di Giambenedetto, Simona; De Luca, Andrea
1-gen-2017 The anti-vascular endothelial growth factor receptor-1 monoclonal antibody D16F7 inhibits invasiveness of human glioblastoma and glioblastoma stem cells Atzori, Maria Grazia; Tentori, Lucio; Ruffini, Federica; Ceci, Claudia; Lisi, Lucia; Bonanno, Elena; Scimeca, Manuel; Eskilsson, Eskil; Daubon, Thomas; Miletic, Hrvoje; Ricci Vitiani, Lucia; Pallini, Roberto; Navarra, Pierluigi; Bjerkvig, Rolf; D'Atri, Stefania; Lacal, Pedro Miguel; Graziani, Grazia